United States - English - NLM (National Library of Medicine)

bausch & lomb incoporated - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), prednisolone sodium phosphate (unii: iv021nxa9j) (prednisolone - unii:9phq9y1olm) - sulfacetamide sodium 100 mg in 1 ml - sulfacetamide sodium and prednisolone sodium phosphate ophthalmic solution is indicated for corticosteroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active

United States - English - NLM (National Library of Medicine)

noble pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sodium sulfacetamide 10% & sulfur 5% cleanser is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sodium sulfacetamide 10% & sulfur 5% cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sodium sulfacetamide 10% & sulfur 5% cleanser is not to be used by patients with kidney disease.

United States - English - NLM (National Library of Medicine)

noble pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - indications: sodium sulfacetamide 10% and sulfur 2% cleanser is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: sodium sulfacetamide 10% and sulfur 2% cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sodium sulfacetamide 10% and sulfur 2% cleanser is not to be used by patients with kidney disease.

United States - English - NLM (National Library of Medicine)

gabar health sciences corp. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - indications: sodium sulfacetamide 10% & sulfur 5% cleanser is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: sodium sulfacetamide 10% & sulfur 5% cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur, or any other component of this preparation. sodium sulfacetamide 10% & sulfur 5% cleanser is not to be used by patients with kidney disease.

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 100 mg in 1 ml - indications: bp cleansing wash is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: bp cleansing wash is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. bp cleansing wash is not to be used by patients with kidney disease. pediatric use - safety and effectiveness in children under the age of 12 have not been established.

United States - English - NLM (National Library of Medicine)

gabar health sciences corp. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - indications: sodium sulfacetamide 10% - sulfur 2% cleanser is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: sodium sulfacetamide 10% - sulfur 2% cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sodium sulfacetamide 10% - sulfur 2% cleanser is not to be used by patients with kidney disease.

United States - English - NLM (National Library of Medicine)

medimetriks pharmaceuticals, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 100 mg in 1 g - sumaxin® (sodium sulfacetamide 10% & sulfur 4%) cleansing pads are indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sumaxin® (sodium sulfacetamide 10% & sulfur 4%) cleansing pads are contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sumaxin® (sodium sulfacetamide 10% & sulfur 4%) cleansing pads are not to be used by patients with kidney disease.

United States - English - NLM (National Library of Medicine)

exact-rx, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - indications and usage: sodium sulfacetamide 10% wash is intended for topical application in the following scaling dematoses: seborrheic dermatitis and sebonthea sicca (dandruff). it also is indicated for the treatment of secondary bacterial infections of the skin due to organisms susceptible to sulfonamides. contraindications: sodium sulfacetamide 10% wash is contraindicated in persons with known or suspected hypersensitivity to sulfonamides or to any of the ingredients of the product. pediatric use: safety and effectiveness in children under the age of 12 years have not been established.

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 100 mg in 1 g - indications and usage: bp 10-1 wash is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: bp 10-1 wash is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. bp 10-1 wash is not to be used by patients with kidney disease. pediatric use - safety and effectiveness in children under the age of 12 have not been established.

United States - English - NLM (National Library of Medicine)

exact-rx, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - indications : sodium sulfacetemide 10% wash is intended for topical application in the following scaling dermatoses: seborrheic dermatisis and seborrhea sicca (dandruff). it also is indicated for the treatment of secondary bacterial infections of the skin due to organisms susceptible to sulfonamides. contraindications: sodium sulfacetamide 10% wash is contraindicated in persons with know or suspected hypersensitivity to sulfonamides.